Insight by Abdul Wasay, Chief Operating Officer at The Business Research Company In response to fluctuating tariffs and geopolitical trade developments, the Pharmaceutical Intermediates Market Outlook 2025 analyses how businesses are adapting through supply chain diversification and strategic sourcing.
The Pharmaceutical Intermediates market has witnessed a consistent increase in size in the past few years. The market size is expected to increase from $33.37 billion in 2024 to $34.95 billion in 2025. This growth corresponds to a compound annual growth rate (CAGR) of 4.7%.
The Pharmaceutical Intermediates market is projected to expand to a size of $46.04 billion by the year 2029. This expansion is expected to occur at a compound annual growth rate (CAGR) of 7.1%.
Download the Free Sample Now:The key Drivers in the pharmaceutical intermediates market are:
• Rising prevalence of chronic diseases
• Aging population contributing to greater health risks
• Lifestyle changes and rapid urbanization leading to more health conditions
• Increasing need for effective medications to manage chronic conditions.
The pharmaceutical intermediatesmarket covered in this report is segmented –
1) By Product: Chemical Intermediate, Bulk Drug Intermediate, Other Products
2) By Category: Branded Drug Intermediate, Generic Drug Intermediate
3) By Application: Analgesics, Anti-Infective Drugs, Cardiovascular Drugs, Oral Antidiabetic Drugs, Antimicrobial Drugs, Other Applications
4) By End-User: Biotech And Pharma Companies, Research Institutions, Other End-Users
The key trends in the pharmaceutical intermediates market are:
• Innovation in product lines, such as API Intermediates, is becoming a trend among major pharmaceutical intermediates market players.
• There is increased focus on the production of intermediates for specific application areas like digestive system medications.
• The pharmaceutical market is shifting towards intermediates that serve as building blocks for pharmaceutically active ingredients.
• The use of pharmaceutical intermediates for the production of medications addressing specific disorders such as gastrointestinal disorders, indicates a trend for targeted therapy.
The key players in the pharmaceutical intermediates market are:
• BASF SE
• Sanofi SA
• Thermo Fisher Scientific Inc
• Meck KGaA
• Dishman Carbogen Amcis Ltd
• Evonik Industries AG
• Arkema Inc.
• Lonza Group AG
• Wuxi AppTec co. Ltd
• Aurobindo Pharma Lmited.
• Lianhe Chemical Technology Co. Ltd.
• Cambrex Corporation
• Vertellus Holdings LLC.
• Hovione LLC
• Hikal Ltd.
• Codexis Inc.
• Aceto Corporation
• Interchem Corporation
• Midas Pharma GmbH
• Arbiom
• Dextra Laboratories Ltd.
• A. R. Life Sciences
• Ingenza Ltd.
• Chiracon GmbH
• Dyadic International Inc.
• Elam Pharma Pvt Ltd
• Yin-sheng Bio-tech Co. Ltd.
• Green Vision Life Sciences
• Sibylla Biotech s.r.l.
• Pfizer CentreOne
North America was the largest region in the pharmaceutical intermediates market in 2024